Personalised radiation treatment a valuable alternative

The interactive workshop was attended by some 75 medical professionals from around South Africa, including medical and radiation oncologists, radiographers,

The future of oncology practice

For almost a decade the ICON Group, which recently restructured its business units under the ICON brand, has advocated for

Engineering reproduction in the oncofertility field

“When patients are given the devastating news of cancer, they may be focused on cancer and unable to think about

Immunotherapy, biomarkers revolutionise cancer treatment

Speaking to Medical Chronicle ahead of the European Society for Medical Oncology (ESMO) Summit Africa, held in Cape Town last

How often do patients need to be screened?

World Cancer Day was on 4th February. This initiative by the Union for International Cancer Control (UICC), will again focus

Do R&D costs justify prices of cancer drugs?

High costs and the risks of R&D have long been used to justify the high prices of cancer drugs. However, new research has found that cancer drugs have generated returns far in excess of possible R&D costs.

Alcohol often ignored as a breast cancer risk

Despite research clearly linking alcohol use and the risk of breast cancer in women, very few women reduce their alcohol intake, even after the age of 45.

DNA secrets of prostate cancer in African men revealed

A new pilot research study is the first in the world to sequence the entire tumour DNA of African men with prostate cancer, and has found significant differences compared to the tumour DNA of non-Africans.

Mouth ulcers and sore gums a common side effect of cancer treatment

A common side effect of chemotherapy and some head and neck radiation treatment is oral mucositis – painful mouth ulcers and inflammation in the mouth.

7 hygiene myths and misconceptions

With a second round of recent product recalls by retailers, the country-wide Listeria outbreak is a very real reminder why South Africans should be taking a closer look at their hygiene practices.

HPV and cervical cancer crisis in SA

While most people are aware that Human Papilloma Virus (HPV) causes genital warts, it’s concerning how few are aware of HPV’s connection to cervical and other cancers.

SA’s first biosimilar oncology drug authorised for use

Filgrastim Teva, manufactured by Teva and distributed in South Africa by Cipla, paves the way for more affordable treatments to